Leadership Evolution: Alvotech Names Graver as New CEO While Wessman Moves to Full-Time Executive Chairman Role

BoredStaker · 2026-01-12T18:15:55+00:00

Alvotech has announced a leadership transition with Lisa Graver becoming the new CEO, succeeding founder Robert Wessman, who will remain Executive Chairman. The phased transition aims for a seamless handover by Q1 2026, reflecting structured leadership development.

BoredStaker

2026-01-12 18:15:55

Abstract generation in progress

In a significant management restructuring, Alvotech (ALVO), a prominent manufacturer of biosimilar pharmaceuticals, has unveiled its plan to transition leadership. Lisa Graver has been designated as the company’s new Chief Executive Officer, taking over from Robert Wessman, who established Alvotech in 2013 and has served as both Chairman and CEO since the company’s public debut in 2022.

The Transition Timeline and Structure

The leadership change will occur in phases. Wessman, who assumed the CEO position at the start of 2023, will formally relinquish this role by the end of Q1 2026. Rather than stepping away entirely, he will dedicate himself fully to his Executive Chairman responsibilities, ensuring continuity during this organizational shift. The transition kicks off immediately, with Graver collaborating closely with Wessman and the broader executive team throughout the coming months to facilitate a seamless handover.

Who is Lisa Graver?

Graver brings substantial experience to the role, having maintained a professional partnership with Wessman spanning more than two decades. Most recently, she served as Chief Executive Officer of Alvogen until its acquisition by Lotus Pharmaceutical in December 2025. Additionally, Graver has been contributing as a Board member of Alvotech since the company’s initial public offering in 2022. Upon her appointment as CEO, she will resign from her Board position to focus entirely on executive responsibilities.

Leadership Perspective

Reflecting on the succession plan, Wessman commented: “When I stepped into the CEO role at the beginning of 2023, it was with a clear objective to strengthen day-to-day leadership and position the company for its next phase. My intention was not to combine the roles of Chairman and CEO on a long-term basis, and the Board and I have been planning for a CEO succession accordingly for some time.” This deliberate approach underscores the company’s commitment to structured leadership development and strategic planning.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.